000 | 01130 a2200337 4500 | ||
---|---|---|---|
005 | 20250518011238.0 | ||
264 | 0 | _c20190829 | |
008 | 201908s 0 0 fre d | ||
022 | _a1773-0597 | ||
024 | 7 |
_a10.1016/j.jfo.2018.06.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCallet, M | |
245 | 0 | 0 |
_a[Omalizumab for severe vernal keratoconjunctivitis]. _h[electronic resource] |
260 |
_bJournal francais d'ophtalmologie _cDec 2018 |
||
300 |
_ae499-e500 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 |
_aAnti-Allergic Agents _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aConjunctivitis, Allergic _xdrug therapy |
650 | 0 | 4 |
_aDrug Resistance _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOmalizumab _xpharmacology |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aStolowy, N | |
700 | 1 | _aZanin, E | |
700 | 1 | _aDenis, D | |
773 | 0 |
_tJournal francais d'ophtalmologie _gvol. 41 _gno. 10 _gp. e499-e500 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jfo.2018.06.001 _zAvailable from publisher's website |
999 |
_c29087680 _d29087680 |